Literature DB >> 18191734

Angiographic predictors of 6-month patency of bypass grafts implanted to the right coronary artery a prospective randomized comparison of gastroepiploic artery and saphenous vein grafts.

David Glineur1, William D'hoore, Gebrine El Khoury, Sixte Sondji, Gregory Kalscheuer, Jean-Christophe Funken, Jean Rubay, Alain Poncelet, Parla Astarci, Robert Verhelst, Philippe Noirhomme, Claude Hanet.   

Abstract

OBJECTIVES: The purpose of this study was to define the pre-operative angiographic variables that could influence graft patency and flow pattern.
BACKGROUND: Saphenous vein grafts (SVG) and pedicled right gastroepiploic artery (RGEA) grafts are routinely used to revascularize the right coronary artery (RCA). Little is known about the predictive value of objective pre-operative angiographic parameters on the 6-month graft patency and on the interest of these parameters to select the optimal graft material in individual cases.
METHODS: We prospectively enrolled 172 consecutive patient candidates for coronary revascularization. Revascularization of the RCA was randomly performed with SVG in 82 patients or with the RGEA in 90 patients. Both groups were comparable with respect to all pre-operative continuous and discrete variable and risk factors. All patients underwent a systematic angiographic control 6 months after surgery. Pre-operative angiographic parameters included minimal lumen diameter (MLD), percent stenosis and reference diameter of the RCA measured by quantitative angiography (CAAS II system, Pie Medical, Maastricht, the Netherlands), location of the stenosis, run off of the RCA, and regional wall motion of the revascularized territory.
RESULTS: A significant difference in the distribution of flow patterns was observed between SVG and RGEA. In multivariate analysis, graft-dependent flow pattern was significantly associated with both MLD and percent stenosis of the RCA in the RGEA group but with percent stenosis only in the SVG group. In the RGEA group, the proportion of patent grafts was higher when MLD was below a threshold value lying in the third MLD quartile (0.77 to 1.40 mm).
CONCLUSIONS: Pre-operative angiography predicts graft patency in RGEA, whereas the flow pattern in SVG is significantly less influenced by quantitative angiographic parameters.

Entities:  

Mesh:

Year:  2008        PMID: 18191734     DOI: 10.1016/j.jacc.2007.09.030

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Importance of the third arterial graft in multiple arterial grafting strategies.

Authors:  David Glineur
Journal:  Ann Cardiothorac Surg       Date:  2013-07

2.  The art of arterial revascularization-total arterial revascularization in patients with triple vessel coronary artery disease.

Authors:  Brian F Buxton; Philip A Hayward
Journal:  Ann Cardiothorac Surg       Date:  2013-07

Review 3.  Coronary artery bypass graft surgery: the past, present, and future of myocardial revascularisation.

Authors:  Michael Diodato; Edgar G Chedrawy
Journal:  Surg Res Pract       Date:  2014-01-02

4.  Bilateral Internal Thoracic Artery Configuration for Coronary Artery Bypass Surgery: A Prospective Randomized Trial.

Authors:  David Glineur; Munir Boodhwani; Claude Hanet; Laurent de Kerchove; Emiliano Navarra; Parla Astarci; Philippe Noirhomme; Gebrine El Khoury
Journal:  Circ Cardiovasc Interv       Date:  2016-07       Impact factor: 6.546

5.  What should be the role of fractional flow reserve measurement in patients undergoing coronary artery bypass grafting?

Authors:  David Glineur; Aun Yeong Chong; Juan Grau
Journal:  JTCVS Open       Date:  2020-11-11

6.  Coronary artery bypass surgery plus medical therapy versus medical therapy alone for ischaemic heart disease: a protocol for a systematic review with meta-analysis and trial sequential analysis.

Authors:  Ulver Spangsberg Lorenzen; Katrine Bredahl Buggeskov; Emil Eik Nielsen; Naqash Javaid Sethi; Christian Lildal Carranza; Christian Gluud; Janus Christian Jakobsen
Journal:  Syst Rev       Date:  2019-10-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.